AI assistant
PFIZER INC — Director's Dealing 2017
Feb 28, 2017
29831_dirs_2017-02-27_24d7d7be-c942-4b39-9b36-7abece4aa3b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2017-02-23
Reporting Person: HILL CHARLES H (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-23 | Common Stock | F | 22837.0000 | $34.0600 | Disposed | 93553.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-23 | Stock Appreciation Rights | $34.0600 | A | 101461.0000 | Acquired | 2022-02-23 | Common Stock (101461.0000) | Direct |
| 2017-02-23 | Stock Appreciation Rights | $34.0600 | A | 84232.0000 | Acquired | 2024-02-23 | Common Stock (84232.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11007.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.